Drug shortages homepage

Welcome to Drug Shortages Canada, the website for mandatory reporting of drug shortages and discontinuations by market authorization holders. Anyone can search the database of shortage and discontinuation reports. More information can be found on the About & Resources Page.

Early reporting of shortages and discontinuations provides Health Canada, provincial/territorial governments, drug supply chain stakeholders, and health professionals details needed to help them monitor and manage supply. Shortages can be caused by many factors. Some last longer and are more complex than others. Because companies have to report every time they cannot fully meet demand, not all of the reports on this site are cause for concern at the patient level. Most are successfully managed before they impact patients.

The shortage database has a flag that indicates ones that are Tier 3 drug shortages, which are those that could potentially have the highest impact on Canada's drug supply and health care system. A Tier 3 designation is decided by the Tier Assignment Committee (TAC), composed of federal and provincial/territorial governments, healthcare professionals, and industry stakeholders.

Ensuring people can get the medicines they need is a top priority for Health Canada. Health Canada works closely with many partners to prevent shortages, mitigate their impacts, and help resolve them when they occur.

If you would like to know more about shortages like why they happen, how long they last, the actions being taken to reduce impacts on Canadians, and actions you can take if a drug you use is in shortage, please consult the information on Canada.ca.

Below are the newest shortage and discontinuation reports and updates to existing ones.

Drug pills


!!T3 denotes an actual Tier 3 shortage/discontinuation

!T3 denotes an anticipated Tier 3 shortage/discontinuation

Shortage Reports

Brand name Company Name Status Strength Update Date Updated View Report
FLOVENT HFA GLAXOSMITHKLINE INC Actual shortage 250MCG Updated Report 2023-12-08 208284
SEREVENT DISKUS (50MCG/DOSE) GLAXOSMITHKLINE INC Actual shortage 50MCG Updated Report 2023-12-08 212066
ARNUITY ELLIPTA GLAXOSMITHKLINE INC Actual shortage 100MCG New Report 2023-12-08 212815
!!T3 PROSTIN VR STERILE SOLUTION PFIZER CANADA ULC Actual shortage 500MCG Updated Report 2023-12-08 204343
VOLTAREN OPHTHA NOVARTIS PHARMACEUTICALS CANADA INC Actual shortage 0.1% Updated Report 2023-12-08 205330
DUREZOL NOVARTIS PHARMACEUTICALS CANADA INC Actual shortage 0.05% Updated Report 2023-12-08 207835
ARISTOCORT R BAUSCH HEALTH, CANADA INC. Resolved 0.1% Updated Report 2023-12-08 181211
LODALIS BAUSCH HEALTH, CANADA INC. Resolved 3.75G Updated Report 2023-12-08 166024
PREVYMIS MERCK CANADA INC Anticipated shortage 20MG Updated Report 2023-12-08 210157
CODEINE CONTIN 50MG CONTROLLED RELEASE TAB PURDUE PHARMA Actual shortage 50MG Updated Report 2023-12-08 208850

Discontinuation Reports

Brand name Company Name Status Strength Update Date Updated View Report
LIBTAYO SANOFI-AVENTIS CANADA INC To be discontinued 250MG Updated Report 2023-12-08 212566
LIDEX BAUSCH HEALTH, CANADA INC. Discontinued 0.05% New Report 2023-12-08 212804
LODALIS BAUSCH HEALTH, CANADA INC. Discontinued 3.75G New Report 2023-12-08 212799
NUCALA GLAXOSMITHKLINE INC Discontinued 100MG New Report 2023-12-07 212755
TEVA-ECTOSONE TEVA CANADA LIMITED Discontinued 0.1% New Report 2023-12-05 212526